KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 123 filers reported holding KALA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,000 | -8.3% | 51,716 | +24.8% | 0.00% | – |
| Q2 2022 | $12,000 | -99.0% | 41,442 | -75.8% | 0.00% | -100.0% |
| Q1 2021 | $1,156,000 | -63.6% | 171,523 | -63.3% | 0.00% | -66.7% |
| Q4 2020 | $3,172,000 | +78.8% | 467,902 | +177.2% | 0.01% | 0.0% |
| Q2 2020 | $1,774,000 | +769.6% | 168,815 | +627.7% | 0.01% | +350.0% |
| Q1 2020 | $204,000 | -27.9% | 23,200 | -59.9% | 0.00% | +100.0% |
| Q4 2018 | $283,000 | +164.5% | 57,876 | +432.0% | 0.00% | – |
| Q3 2018 | $107,000 | – | 10,879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vahanian & Associates Financial Planning Inc. | 1,046,484 | $1,266,000 | 1.02% |
| RA Capital Management | 10,874,613 | $13,158,000 | 0.23% |
| Samsara BioCapital, LLC | 601,162 | $727,000 | 0.14% |
| Matisse Capital | 41,400 | $50,000 | 0.04% |
| Manteio Capital LLC | 19,546 | $24,000 | 0.03% |
| Covestor Ltd | 17,766 | $21,000 | 0.03% |
| Knights of Columbus Asset Advisors LLC | 241,857 | $293,000 | 0.02% |
| Virtu Financial LLC | 126,231 | $153,000 | 0.02% |
| Aquatic Capital Management LLC | 6,200 | $8,000 | 0.02% |
| CAXTON CORP | 13,155 | $16,000 | 0.01% |